Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Che

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
BMC Cancer|April 17, 2025
Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective studyJun-Shuai Xue, Nuersimanguli Maimaitiming, Bo-Lun Zhang, et al.
Signal Transduction and Targeted Therapy|October 29, 2021
Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanismMengwen Zhang, Xingyi Pan, Kenji Fujiwara, et al.
Molecular Carcinogenesis|January 14, 2011
Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitisJian Xu, Chen Wu, Xu Che, et al.
Life Sciences|April 13, 2025
PPP3CB inhibits pancreatic cancer progression by promoting ATOH8 translocation and transcriptionally regulating Sp1Xiao Dong, Lixia Wu, Libao Gong, et al.
Annals of Translational Medicine|August 12, 2022
GRSF1 predicts an unfavorable prognosis and promotes tumorigenesis in lung adenocarcinoma based on bioinformatics analysis and <i>in vitro</i> validationRong Huang, Lin Xu, Qichen Chen, et al.
American Journal of Cancer Research|February 13, 2023
At least 16 lymph nodes are recommended to examine during pancreaticoduodenectomy in ampullary adenocarcinomaXiaojie Zhang, Chongyuan Sun, Lulu Zhao, et al.
Cell Reports|August 5, 2024
Increased viral tolerance mediates by antiviral RNA interference in bat cellsYunpeng Dai, Binbin Wang, Jiaxin Wang, et al.
Journal of Nanobiotechnology|February 19, 2026
Novel Homo-SELEX for selecting universal aptamer for cross-species kidney injury biomarker KIM-1 in muti-scenario situ imagingHe Yang, Zaihui Du, Longjiao Zhu, et al.
Molecular Cancer Therapeutics|September 3, 2017
Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer TreatmentAgnieszka A Rucki, Qian Xiao, Stephen Muth, et al.
Zhonghua Yi Xue Za Zhi|February 9, 2010
[Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases]Yi Wang, Ping Zhao, Cheng-feng Wang, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
BMC Cancer|April 17, 2025
Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective studyJun-Shuai Xue, Nuersimanguli Maimaitiming, Bo-Lun Zhang, et al.
Signal Transduction and Targeted Therapy|October 29, 2021
Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanismMengwen Zhang, Xingyi Pan, Kenji Fujiwara, et al.
Molecular Carcinogenesis|January 14, 2011
Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitisJian Xu, Chen Wu, Xu Che, et al.
Life Sciences|April 13, 2025
PPP3CB inhibits pancreatic cancer progression by promoting ATOH8 translocation and transcriptionally regulating Sp1Xiao Dong, Lixia Wu, Libao Gong, et al.
Annals of Translational Medicine|August 12, 2022
GRSF1 predicts an unfavorable prognosis and promotes tumorigenesis in lung adenocarcinoma based on bioinformatics analysis and <i>in vitro</i> validationRong Huang, Lin Xu, Qichen Chen, et al.
American Journal of Cancer Research|February 13, 2023
At least 16 lymph nodes are recommended to examine during pancreaticoduodenectomy in ampullary adenocarcinomaXiaojie Zhang, Chongyuan Sun, Lulu Zhao, et al.
Cell Reports|August 5, 2024
Increased viral tolerance mediates by antiviral RNA interference in bat cellsYunpeng Dai, Binbin Wang, Jiaxin Wang, et al.
Journal of Nanobiotechnology|February 19, 2026
Novel Homo-SELEX for selecting universal aptamer for cross-species kidney injury biomarker KIM-1 in muti-scenario situ imagingHe Yang, Zaihui Du, Longjiao Zhu, et al.
Molecular Cancer Therapeutics|September 3, 2017
Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer TreatmentAgnieszka A Rucki, Qian Xiao, Stephen Muth, et al.
Zhonghua Yi Xue Za Zhi|February 9, 2010
[Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases]Yi Wang, Ping Zhao, Cheng-feng Wang, et al.
Pageof 12